Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elevance Health, Inc. stock logo
ELV
Elevance Health
$538.61
+1.0%
$515.17
$412.00
$542.07
$125.18B0.791.04 million shs456,566 shs
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$87.42
+2.7%
$90.03
$60.57
$96.12
$52.68B1.13.71 million shs3.42 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$385.45
+1.3%
$385.21
$254.85
$403.76
$136.72B1.391.59 million shs882,172 shs
Stryker Co. stock logo
SYK
Stryker
$330.86
+0.5%
$345.60
$249.98
$361.41
$126.04B0.911.33 million shs980,396 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elevance Health, Inc. stock logo
ELV
Elevance Health
+0.99%+2.47%+4.71%+6.43%+17.25%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
+2.74%+2.77%-6.05%+2.83%-1.61%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+1.34%+2.07%-1.41%-0.71%+27.38%
Stryker Co. stock logo
SYK
Stryker
+0.48%+1.26%-5.70%-3.25%+15.85%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.4305 of 5 stars
2.55.04.20.03.12.52.5
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.691 of 5 stars
2.35.00.04.02.83.32.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.8118 of 5 stars
2.45.00.04.03.32.53.1
Stryker Co. stock logo
SYK
Stryker
4.9523 of 5 stars
3.43.03.34.23.02.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.92
Moderate Buy$587.429.06% Upside
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.56
Moderate Buy$93.276.69% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.76
Moderate Buy$396.172.78% Upside
Stryker Co. stock logo
SYK
Stryker
2.78
Moderate Buy$365.9410.60% Upside

Current Analyst Ratings

Latest ISRG, EW, SYK, and ELV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$100.00 ➝ $101.00
5/2/2024
Stryker Co. stock logo
SYK
Stryker
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$372.00 ➝ $376.00
5/1/2024
Stryker Co. stock logo
SYK
Stryker
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$364.00 ➝ $381.00
5/1/2024
Stryker Co. stock logo
SYK
Stryker
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$348.00 ➝ $405.00
5/1/2024
Stryker Co. stock logo
SYK
Stryker
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$339.00 ➝ $351.00
5/1/2024
Stryker Co. stock logo
SYK
Stryker
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$375.00 ➝ $380.00
5/1/2024
Stryker Co. stock logo
SYK
Stryker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$350.00 ➝ $375.00
5/1/2024
Stryker Co. stock logo
SYK
Stryker
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/1/2024
Stryker Co. stock logo
SYK
Stryker
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$367.00 ➝ $378.00
5/1/2024
Stryker Co. stock logo
SYK
Stryker
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$366.00 ➝ $369.00
4/26/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$94.00 ➝ $99.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elevance Health, Inc. stock logo
ELV
Elevance Health
$171.75B0.73$42.14 per share12.78$169.07 per share3.19
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$6.14B8.57$2.83 per share30.85$11.08 per share7.89
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$7.12B19.19$5.48 per share70.32$38.03 per share10.14
Stryker Co. stock logo
SYK
Stryker
$20.96B6.01$13.63 per share24.27$50.33 per share6.57

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.99B$26.4620.3612.941.163.64%20.62%7.35%7/17/2024 (Estimated)
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$1.40B$2.3237.6828.113.5923.01%22.86%16.52%7/24/2024 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.80B$5.5469.5866.924.9327.16%12.91%11.22%7/18/2024 (Estimated)
Stryker Co. stock logo
SYK
Stryker
$3.17B$8.7637.7724.782.5416.03%23.05%10.88%8/1/2024 (Estimated)

Latest ISRG, EW, SYK, and ELV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024Q1 24
Stryker Co. stock logo
SYK
Stryker
$2.36$2.50+$0.14$2.95$5.10 billion$5.24 billion      
4/25/2024Q1 2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.64$0.66+$0.02$0.74$1.58 billion$1.60 billion    
4/18/2024Q1 2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.54$10.64+$0.10$11.69$42.49 billion$42.27 billion      
4/18/2024Q1 24
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.3990$1.50+$0.1010$0.81$1.87 billion$1.89 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.521.21%+15.93%24.64%13 Years
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Stryker Co. stock logo
SYK
Stryker
$3.200.97%+9.00%36.53%31 Years

Latest ISRG, EW, SYK, and ELV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/19/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.631.2%6/10/20246/10/20246/25/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.54
1.37
1.37
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.08
3.75
2.67
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
5.55
4.61
Stryker Co. stock logo
SYK
Stryker
0.56
1.71
0.99

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Stryker Co. stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
1.27%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.80%
Stryker Co. stock logo
SYK
Stryker
5.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
104,900232.42 million231.74 millionOptionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
19,800602.60 million594.95 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
13,676354.71 million351.87 millionOptionable
Stryker Co. stock logo
SYK
Stryker
52,000380.95 million360.00 millionOptionable

ISRG, EW, SYK, and ELV Headlines

SourceHeadline
Stryker Corporation: Stryker declares a $0.80 per share quarterly dividendStryker Corporation: Stryker declares a $0.80 per share quarterly dividend
finanznachrichten.de - May 9 at 6:40 PM
National Pension Service Purchases 14,830 Shares of Stryker Co. (NYSE:SYK)National Pension Service Purchases 14,830 Shares of Stryker Co. (NYSE:SYK)
marketbeat.com - May 9 at 1:05 PM
Stryker declares a $0.80 per share quarterly dividendStryker declares a $0.80 per share quarterly dividend
globenewswire.com - May 9 at 8:00 AM
Barlow Wealth Partners Inc. Buys Shares of 2,947 Stryker Co. (NYSE:SYK)Barlow Wealth Partners Inc. Buys Shares of 2,947 Stryker Co. (NYSE:SYK)
marketbeat.com - May 8 at 6:49 PM
Stryker completes 1st Infinity Total Ankle surgeries in EuropeStryker completes 1st Infinity Total Ankle surgeries in Europe
beckersspine.com - May 8 at 6:40 PM
Charles Schwab Investment Management Inc. Boosts Stake in Stryker Co. (NYSE:SYK)Charles Schwab Investment Management Inc. Boosts Stake in Stryker Co. (NYSE:SYK)
marketbeat.com - May 7 at 9:42 PM
Stryker reports first European procedures using Adaptis, Everlast total anklesStryker reports first European procedures using Adaptis, Everlast total ankles
massdevice.com - May 7 at 5:26 PM
First Surgeries Using Stryker’s Infinity With Adaptis and Everlast Successfully Completed in EuropeFirst Surgeries Using Stryker’s Infinity With Adaptis and Everlast Successfully Completed in Europe
finance.yahoo.com - May 7 at 6:53 AM
First Surgeries Using Strykers Infinity With Adaptis and Everlast Successfully Completed in EuropeFirst Surgeries Using Stryker's Infinity With Adaptis and Everlast Successfully Completed in Europe
businesswire.com - May 7 at 2:10 AM
5 things to know about Strykers orthopedics and spine president5 things to know about Stryker's orthopedics and spine president
beckersspine.com - May 6 at 8:52 PM
National Bank of Canada FI Purchases 26,319 Shares of Stryker Co. (NYSE:SYK)National Bank of Canada FI Purchases 26,319 Shares of Stryker Co. (NYSE:SYK)
marketbeat.com - May 6 at 1:37 PM
Barclays Boosts Stryker (NYSE:SYK) Price Target to $376.00Barclays Boosts Stryker (NYSE:SYK) Price Target to $376.00
americanbankingnews.com - May 5 at 6:46 AM
Stryker Co. (NYSE:SYK) Shares Bought by First National Trust CoStryker Co. (NYSE:SYK) Shares Bought by First National Trust Co
marketbeat.com - May 4 at 2:31 PM
Shareholders Will Probably Hold Off On Increasing Stryker Corporations (NYSE:SYK) CEO Compensation For The Time BeingShareholders Will Probably Hold Off On Increasing Stryker Corporation's (NYSE:SYK) CEO Compensation For The Time Being
finance.yahoo.com - May 4 at 11:11 AM
Stryker Co. (NYSE:SYK) to Post Q3 2024 Earnings of $2.90 Per Share, Roth Capital ForecastsStryker Co. (NYSE:SYK) to Post Q3 2024 Earnings of $2.90 Per Share, Roth Capital Forecasts
americanbankingnews.com - May 4 at 4:16 AM
Two Stryker Seniors Awarded Scholarships From Bryan Area FoundationTwo Stryker Seniors Awarded Scholarships From Bryan Area Foundation
thevillagereporter.com - May 3 at 4:24 PM
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook (SYK)Boston Scientific Bucks the Medtech Slow Down and Raises Outlook (SYK)
marketbeat.com - May 3 at 1:38 PM
Stryker Corporation Just Beat EPS By 6.2%: Heres What Analysts Think Will Happen NextStryker Corporation Just Beat EPS By 6.2%: Here's What Analysts Think Will Happen Next
finance.yahoo.com - May 3 at 11:19 AM
Stryker Co. (NYSE:SYK) Expected to Post Q3 2024 Earnings of $2.90 Per ShareStryker Co. (NYSE:SYK) Expected to Post Q3 2024 Earnings of $2.90 Per Share
marketbeat.com - May 3 at 9:16 AM
Stifel Nicolaus Keeps Their Buy Rating on Stryker (SYK)Stifel Nicolaus Keeps Their Buy Rating on Stryker (SYK)
markets.businessinsider.com - May 3 at 6:19 AM
UBS Group Increases Stryker (NYSE:SYK) Price Target to $351.00UBS Group Increases Stryker (NYSE:SYK) Price Target to $351.00
americanbankingnews.com - May 3 at 6:16 AM
Stryker (NYSE:SYK) PT Raised to $369.00Stryker (NYSE:SYK) PT Raised to $369.00
americanbankingnews.com - May 3 at 6:16 AM
Stryker (NYSE:SYK) PT Raised to $380.00Stryker (NYSE:SYK) PT Raised to $380.00
americanbankingnews.com - May 3 at 6:16 AM
Stryker (NYSE:SYK) PT Raised to $378.00 at Robert W. BairdStryker (NYSE:SYK) PT Raised to $378.00 at Robert W. Baird
americanbankingnews.com - May 3 at 6:16 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Elevance Health logo

Elevance Health

NYSE:ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Edwards Lifesciences logo

Edwards Lifesciences

NYSE:EW
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Intuitive Surgical logo

Intuitive Surgical

NASDAQ:ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Stryker logo

Stryker

NYSE:SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.